Emmitte, Kyle A
- Vanderbilt University · Pharmacology (NIH department code)
From the FY2021 NIH awards this investigator leads as contact PI. The department is the award's.
FY2021 NIH rank #30,199
- Early Career
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2019 through FY2021Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2021 award categories
- Pharmacology
NIH Funding · FY2021
Linked Award Amount
$352.9K
Full award amounts, FY2021
Award Records
1
Records listing this PI
Award-Linked Rank
#30,199
By linked amount among FY2021 PIs
Earliest Year Loaded
2019
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2021 award records by amount
NIH award records listing Emmitte, Kyle A as a PI. Multi-PI records show the full award amount for context.
- 5R33NS109521-03R33Contact PISlack Potassium Channel Inhibitors for the Treatment of Childhood EpilepsiesVanderbilt University · Pharmacology (NIH department code)$352.9Kaward amount
Award organization
Organizations that administered FY2021 awards listing Emmitte, Kyle A as a PI.
FY2021 award administered by Vanderbilt University (TN).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2019First NIH AwardVanderbilt University
- 2021$500K Cumulative Funding